ACCURACY;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG HALF LIFE;
FLUORESCENCE ANALYSIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
KOREA;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NORMAL HUMAN;
PROCESS DEVELOPMENT;
PRODUCT RECOVERY;
QUANTITATIVE ANALYSIS;
SEPARATION TECHNIQUE;
SINGLE DRUG DOSE;
TIME TO MAXIMUM PLASMA CONCENTRATION;
VOLUNTEER;
BLOOD;
CHEMISTRY;
ECONOMICS;
METHODOLOGY;
REPRODUCIBILITY;
SAMPLE SIZE;
SENSITIVITY AND SPECIFICITY;
SPECTROFLUOROMETRY;
TIME;
VALIDATION STUDY;
ACETONITRILES;
ADULT;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
BIPHENYL COMPOUNDS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
LOSARTAN;
MALE;
REPRODUCIBILITY OF RESULTS;
SAMPLE SIZE;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, FLUORESCENCE;
TETRAZOLES;
TIME FACTORS;
YOUNG ADULT;
Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes
Bourrié M, Meunier V, Berger Y and Fabre G. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes. Drug Metabolism and Disposition 1999; 27: 288-296.
Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography
Caudron E, Laurent S, Billaud EM and Prognon P. Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography. Journal of Chromatography B 2004; 801: 339-345.
High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine
Chang SY, Whigan DB, Vachharajani NN and Patel R. High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine. Journal of Chromatography B 1997; 702: 149-155.
Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
Chiou WL. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinetics and Biopharmaceutics 1978; 6: 539-546.
Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: A Canadian perspective
Coyle D, Rodby R, Soroka S, Levin A, Muirhead N, de Cotret PR, Chen R and Palmer A. Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective. Clinical Therapeutics 2007; 29: 1508-1523.
Irbesartan: A review of its use in hypertension and in the management of diabetic nephropathy
Croom KF, Curran MP, Goa KL and Perry CM. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs 2004; 64: 999-1028.
Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography
Erk N. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography. Journal of Chromatography B 2003; 784: 195-201.
Gillis JC and Markham A. Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs 1997; 54: 885-902.
Gillis JC and Markham A. Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs 1997; 54: 885-902.
10
0037040623
Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection
González L, López JA, Alonso JM and Jiménez RM. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography A 2002; 949: 49-60.
Biocompatible intube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine
Nie J, Zhang M, Fan Y, Wen Y, Xiang B and Feng YQ. Biocompatible intube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine. Journal of Chromatography B 2005; 828: 62-69.
Human pharmacokinetic/pharmacodynamic profile of irbesartan: A new potent angiotensin II receptor antagonist
Ruilope L. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist. Journal of Hypertension (Supplement) 1997; 15: S15-S20.
Liquid chromatographic determination of irbesartan in human plasma
Shakya AK, Al-Hiari YM and Alhamami OM. Liquid chromatographic determination of irbesartan in human plasma. Journal of Chromatography B 2007; 848: 245-250.